MEDP

Medpace Holdings, Inc.

Halal Rating :
Comfortable
Last Price $337.66 Last updated:
Market Cap $11.01b
7D Change -2.39%
1 Year Change 9.14%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Services
  • Business Services
  • Services – Research
  • Development
  • Testing Labs
Exchange NASDAQ
Next Earnings Date Oct. 21, 2024

Medpace Holdings, Inc. is a clinical contract research organization (CRO) providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The company offers a full suite of services supporting the clinical development process from Phase I-IV clinical trials to post-marketing activities.

The company provides services including clinical trial management, patient recruitment, data management, biostatistical analysis, medical writing, laboratory services, and regulatory consulting. Their focus is on conducting clinical trials in therapeutic areas such as oncology, cardiovascular, metabolic disease, endocrinology, central nervous system, and anti-viral/anti-infective treatments.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $533.32m $421.04m - - 0.00% 0.00%
June 30, 2024 $528.1m $422.95m - - 0.00% 0.00%
March 31, 2024 $511.04m $406.98m - - 0.00% 0.00%

Company Impact

Help us evaluate Medpace Holdings, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates